Antiviral Mechanism of Action of Epigallocatechin-3-O-gallate and Its Fatty Acid Esters

被引:97
作者
Kaihatsu, Kunihiro [1 ]
Yamabe, Miyuki [1 ]
Ebara, Yasuhito [1 ]
机构
[1] Kobe Univ, Grad Sch Human Dev & Environm, 3-11 Tsurukabuto, Kobe, Hyogo 6578501, Japan
来源
MOLECULES | 2018年 / 23卷 / 10期
关键词
catechin; epigallocatechin-3-O-gallate; virus inhibition; attachment; entry; fusion; replication; budding; fatty acid derivative; GREEN TEA POLYPHENOL; SIMPLEX-VIRUS TYPE-1; INFLUENZA-VIRUS; ANTIINFLUENZA VIRUS; GALLATE; INHIBITION; CATECHIN; EGCG; DERIVATIVES; ENTRY;
D O I
10.3390/molecules23102475
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Epigallocatechin-3-O-gallate (EGCG) is the major catechin component of green tea (Cameria sinensis), and is known to possess antiviral activities against a wide range of DNA viruses and RNA viruses. However, few studies have examined chemical modifications of EGCG in terms of enhanced antiviral efficacy. This paper discusses which steps of virus infection EGCG interferes with, citing previous reports. EGCG appears most likely to inhibits the early stage of infections, such as attachment, entry, and membrane fusion, by interfering with viral membrane proteins. According to the relationships between structure and antiviral activity of catechin derivatives, the 3-galloyl and 5'-OH group of catechin derivatives appear critical to antiviral activities. Enhancing the binding affinity of EGCG to virus particles would thus be important to increase virucidal activity. We propose a newly developed EGCG-fatty acid derivative in which the fatty acid on the phenolic hydroxyl group would be expected to increase viral and cellular membrane permeability. EGCG-fatty acid monoesters showed improved antiviral activities against different types of viruses, probably due to their increased affinity for virus and cellular membranes. Our study promotes the application of EGCG-fatty acid derivatives for the prevention and treatment of viral infections.
引用
收藏
页数:21
相关论文
共 56 条
  • [1] Structure-activity studies of (-)-epigallocatechin gallate derivatives as HCV entry inhibitors
    Bhat, Rohit
    Adam, Amna T.
    Lee, Jungeun Jasmine
    Deloison, Gaspard
    Rouille, Yves
    Seron, Karin
    Rotella, David P.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (17) : 4162 - 4165
  • [2] Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action
    Calland, Noemie
    Sahuc, Marie-Emmanuelle
    Belouzard, Sandrine
    Pene, Veronique
    Bonnafous, Pierre
    Mesalam, Ahmed Atef
    Deloison, Gaspard
    Descamps, Veronique
    Sahpaz, Sevser
    Wychowski, Czeslaw
    Lambert, Olivier
    Brodin, Priscille
    Duverlie, Gilles
    Meuleman, Philip
    Rosenberg, Arielle R.
    Dubuisson, Jean
    Rouille, Yves
    Seron, Karin
    [J]. JOURNAL OF VIROLOGY, 2015, 89 (19) : 10053 - 10063
  • [3] (-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry
    Calland, Noemie
    Albecka, Anna
    Belouzard, Sandrine
    Wychowski, Czeslaw
    Duverlie, Gilles
    Descamps, Veronique
    Hober, Didier
    Dubuisson, Jean
    Rouille, Yves
    Seron, Karin
    [J]. HEPATOLOGY, 2012, 55 (03) : 720 - 729
  • [4] The green tea molecule EGCG inhibits Zika virus entry
    Carneiro, Bruno M.
    Batista, Mariana N.
    Braga, Ana Claudia S.
    Nogueira, Mauricio L.
    Rahal, Paula
    [J]. VIROLOGY, 2016, 496 : 215 - 218
  • [5] Epigallocatechin-3-gallate rapidly remodels PAP85-120, SEM1(45-107), and SEM2(49-107) seminal amyloid fibrils
    Castellano, Laura M.
    Hammond, Rebecca M.
    Holmes, Veronica M.
    Weissman, Drew
    Shorter, James
    [J]. BIOLOGY OPEN, 2015, 4 (09): : 1206 - 1212
  • [6] Chang C. W., 1994, Journal of Biomedical Science, V1, P163, DOI 10.1007/BF02253344
  • [7] Green tea and tea polyphenols in cancer prevention
    Chen, D
    Daniel, KG
    Kuhn, DJ
    Kazi, A
    Bhuiyan, M
    Li, LH
    Wang, ZG
    Wan, SB
    Lam, WH
    Chan, TH
    Dou, QP
    [J]. FRONTIERS IN BIOSCIENCE-LANDMARK, 2004, 9 : 2618 - 2631
  • [8] The Green Tea Polyphenol, Epigallocatechin-3-Gallate, Inhibits Hepatitis C Virus Entry
    Ciesek, Sandra
    von Hahn, Thomas
    Colpitts, Che C.
    Schang, Luis M.
    Friesland, Martina
    Steinmann, Joerg
    Manns, Michael P.
    Ott, Michael
    Wedemeyer, Heiner
    Meuleman, Philip
    Pietschmann, Thomas
    Steinmann, Eike
    [J]. HEPATOLOGY, 2011, 54 (06) : 1947 - 1955
  • [9] A Small Molecule Inhibits Virion Attachment to Heparan Sulfate- or Sialic Acid-Containing Glycans
    Colpitts, Che C.
    Schang, Luis M.
    [J]. JOURNAL OF VIROLOGY, 2014, 88 (14) : 7806 - 7817
  • [10] Daidoji T., 2010, CURRENT CHEM BIO, V4, P208